Meet Remission Medical, the telehealth firm that topped this year’s RVA 25 list with nearly 6,000% growth

Posted
RichmondBizSense RVA25Awards AmKayPhotography 87 Cropped 1

Remission Medical CEO Blake Wehman addresses the crowd at RVA 25. (Photos by AmKay Photography)

In a room filled with nearly 400 attendees and 35 of the region’s most up-and-coming businesses, there was one number that truly captured everyone’s attention at last week’s RVA 25 awards ceremony: 5,909.

That’s the average annual revenue growth percentage of the event’s top honoree, Remission Medical.

The local rheumatology-focused telehealth startup took home the top spot at the annual awards celebration, which honored the region’s 25 fastest-growing for-profit companies and 10 fastest-growing nonprofit organizations.

Remission Medical, which offers virtual appointments for rheumatology care, far outpaced the rest of the pack thanks to its three-year average annual revenue growth rate from 2023 to 2025. The next closest company on the list had 277% growth.

Company founder and CEO Blake Wehman told BizSense this week that the RVA 25 rankings were validating to the company’s mission as it continues to grow. Wehman founded Remission in 2022, after having rheumatoid arthritis himself and seeing long wait times to get referrals for appointments with rheumatologists.

The company’s initial business model was to act as its own telehealth clinic geared toward rheumatology patients, before pivoting by contracting out its own practitioners and its back-end platform to other healthcare providers. Remission’s medical staff meets virtually with patients and can order labs, imaging and prescriptions for them, all through the existing virtual portals, electronic health records, scheduling and billing systems of those other doctors’ offices.

Remission makes its money through a fee for services paid by those other healthcare providers. 

Remission’s first two health system customers under that new model were Hampton Roads-based Sentara and Richmond-based OrthoVirginia, which the company signed on a little over two years ago.

Wehman said the company has continued to sign on more providers, including Louisiana-based Ochsner Health and Gundersen Health System in Wisconsin.  

The company currently has partnerships with 14 different healthcare providers, including both for-profit and nonprofit organizations. That’s up from around eight in April of this year. 

As of this month, the company has logged nearly 50,000 medical visits from patients using its services. 

RichmondBizSense RVA25Awards AmKayPhotography 88 scaled

Wehman explained his company’s rapid growth to the crowd at last week’s RVA 25 event.

While nearly 6,000% average annual growth is an eye-popping figure, Wehman said the dramatic increase is due to the fact that the company is still just getting off the ground, with little revenue in 2023 before ramping up its new provider model. 

“Much of 2023 was actually landing our first partnerships, and then, going into 2024 was actually implementing them. An average ‘go-live’ for us may take, like, three months after we’ve signed a contract,” he said. “We’ve been turning on a few health systems pretty much every year.”

Remission has not landed a Richmond-based health system, though Wehman said the company is working on it. He noted that earning the top spot on RVA 25 could provide some attention to help the company grow in its hometown.

“(It) was really just a remarkable honor, and I think, hopefully, we’ll continue to just galvanize more support in the Richmond community,” he said. 

Remission has also been aided in part by a recent $5 million investment from Scott’s Addition-based private equity firm Blue Heron Capital. That capital brought Remission’s total funding from outside investors to around $6.2 million, having previously raised $1.2 million from angel investors. 

Wehman said the Blue Heron raise has allowed Remission to continue to grow its team and make a greater push to sell its services to healthcare providers. 

The company has recently brought on both a chief revenue officer and a chief growth officer, turned its chief technology officer from fractional to full time and brought the company’s total team up to six employees on the leadership side and 24 total nurse practitioners and doctors.  

The company also has a full-time equivalent administrative resident starting in the coming months to support customer growth. 

“I couldn’t be happier with where we’re at. I think Q4 is going to be just an absolutely incredible quarter for us. The best we’ve ever had, by far, and it’s really on the backs of this team,” Wehman said. “At this moment, we’re just focused on closing the year really strong, continuing to execute in 2027 and continuing to expand our portfolio of offerings.”

RichmondBizSense RVA25Awards AmKayPhotography 89 scaled

All of the winners celebrated together at the RVA 25 event.

Wehman told BizSense earlier this year that, just before the Blue Heron deal closed, Remission was “hovering at cash flow positivity” but noted that the company was focused more on growth than profitability, pouring profit back into further growth.

He said this week that the company is still staying on that course.

“Our main focus right now is this kind of wave of new signatures that these hires, this whole team is rallying around. It’s going to give us another year of self-funding and putting our efforts into growth,” he said. “Likely, if you were to ask me this question a year beyond (now), you may have a different answer around how we look at income and profitability, but … we’re continuing to focus and reinvest everything we can to try and support this access to care.” 

Wehman said he and his team were also excited for the recent recognition as a way to bring extra visibility to rheumatoid arthritis.

“To wake up every day knowing that we’re helping patients gain access to care that would otherwise have taken them months, potentially cause damage to their joints or make them have to leave work or go on disability, … it’s why we do it every day,” he said. 

Other companies in the top tier of this year’s RVA 25 included electric parts marketplace startup Mobius Materials and real estate company USA Land Group, with 277% and 274% growth, respectively.  

Last year’s winner was Richmond National, which topped the 2025 list with a three-year average growth rate of roughly 2,000%. It was ranked No. 4 this year with a 176% growth rate. 

Stay tuned to BizSense in the coming days for a feature on Ronald McDonald House Richmond, which topped this year’s first-ever top 10 fastest-growing nonprofits list.

The post Meet Remission Medical, the telehealth firm that topped this year’s RVA 25 list with nearly 6,000% growth appeared first on Richmond BizSense.

Startups